Nitroglycerin can be activated in two ways: one through a specific enzyme in mitochondria, and another through a simple chemical reaction with sulfur-containing molecules like cysteine. Both pathways produce nitric oxide, but the enzyme pathway is more specific and physiologically relevant.
Evidence from Studies
No evidence studies found yet.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
A systematic review could determine the relative contribution of enzymatic versus nonenzymatic pathways to nitroglycerin bioactivation across human and animal studies under controlled conditions.
A systematic review and meta-analysis of all studies comparing nitroglycerin bioactivation in the presence and absence of mitochondrial aldehyde dehydrogenase inhibitors (e.g., cyanamide) versus thiol depletion (e.g., NEM) in human vascular tissue, animal models, and cell lines, with standardized measurement of nitrite, NO, and cGMP.
An RCT could determine whether blocking the enzymatic pathway (with cyanamide) reduces nitroglycerin efficacy more than blocking the nonenzymatic pathway (with thiol depletion offtake).
A double-blind, crossover RCT in 30 healthy volunteers, comparing the vasodilatory response to sublingual nitroglycerin after pretreatment with cyanamide (inhibits enzyme), N-ethylmaleimide (depletes thiols), both, or placebo, measuring forearm blood flow and plasma nitrite.
A cohort study could determine whether individuals with genetic variants reducing mitochondrial aldehyde dehydrogenase activity rely more on nonenzymatic pathways for nitroglycerin response.
A prospective cohort of 200 patients with stable angina and known ALDH2*2 polymorphism (reduced enzyme activity), measuring nitroglycerin-induced vasodilation and plasma nitrite levels before and after thiol depletion with oral cysteine restriction.
A case-control study could compare the relative contribution of enzymatic vs. nonenzymatic pathways in patients with extreme sensitivity or resistance to nitroglycerin.
A case-control study comparing in vitro nitroglycerin bioactivation in vascular tissue from 20 highly sensitive patients versus 20 resistant patients, testing responses to enzyme inhibition and thiol depletion separately.
A cross-sectional study could correlate enzyme activity and thiol levels with nitroglycerin response in a general patient population.
A cross-sectional study measuring mitochondrial aldehyde dehydrogenase activity and plasma cysteine levels in 150 patients on chronic nitroglycerin therapy and correlating both with self-reported efficacy and nitrate dose.